AWS for Industries

Tag: pharmacovigilance

Conducting end-to-end pharmacovigilance workflows using AWS technologies

Introduction Bio-pharmaceutical companies have always had a responsibility to report adverse events (AE), whether in clinical development or post market-approval scenarios, to the Food and Drug Administration (FDA).  The COVID-19 pandemic and the race to find effective treatments for this disease has caused both the FDA and bio-pharmaceutical organizations around the world to re-imagine the […]

Read More

Building Amazon Neptune based MedDRA terminology mapping for pharmacovigilance and adverse event reporting

Life Science companies are witnessing substantial growth in number of Adverse Events (AE) being reported for their products. This may be due to the increase in data volumes coming from journals, articles, social media, and non-standardized data sources. Evolving regulations and increasing pressure to improve quality and patient safety, while maintaining patient privacy rights, and […]

Read More